Oak Ridge Investments’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
Oak Ridge Investments's NEO Position: Q4 2021 in Review
Oak Ridge Investments sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 135,942 shares — an estimated $6.56M sold.
Oak Ridge Investments first reported a position in NEO in Q2 2019 and held it in 10 quarters. The position peaked at $17.2M in Q4 2020. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.
- Oak Ridge Investments reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
- Oak Ridge Investments sold 135,942 NeoGenomics shares in Q4 2021, an estimated $6.56M.
- Oak Ridge Investments first reported a position in NeoGenomics in Q2 2019 and held it in 10 quarters.
- Oak Ridge Investments's NeoGenomics position peaked at $17.2M in Q4 2020.
- 307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.
Based on Oak Ridge Investments's 13F filing for Q4 2021, filed 1 Feb 2022.